# Eliaz Therapeutics Inc. — Form D

Eliaz Therapeutics Inc. of SANTA ROSA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-24. The offering totals $850K, of which $850K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-10-24
- Form: D
- Accession: 0001062993-25-016285
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $850K
- Amount sold: $850K
- Minimum investment: $100K
- Investors: 4
- Date of first sale: 2025-03-28
- Revenue range: Decline to Disclose
- SEC file number: 021-562048

## Issuer

- Name: Eliaz Therapeutics Inc.
- CIK: 0002042609
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 398 TESCONI COURT, SANTA ROSA, CA, 95401
- Phone: 707 542-5856

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Isaac Eliaz | Director | Santa Rosa, CA |
| Isaac Eliaz | Executive Officer | Santa Rosa, CA |
| Milton Goss | Executive Officer | Santa Rosa, CA |

## More

- [CIK 2042609 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2042609&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001062993-25-016285.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.